We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$3.02B
AUM Growth
-$517M
Cap. Flow
-$664M
Cap. Flow %
-22%
Top 10 Hldgs %
32.13%
Holding
158
New
26
Increased
40
Reduced
69
Closed
23

Top Buys

1
CLX icon
Clorox
CLX
+$75.6M
2
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$53M
3
KO icon
Coca-Cola
KO
+$51.7M
4
GNW icon
Genworth Financial
GNW
+$49.3M
5
VER
VEREIT, Inc.
VER
+$43.4M

Top Sells

1
DGX icon
Quest Diagnostics
DGX
+$109M
2
HPQ icon
HP
HPQ
+$82.4M
3
ESRX
Express Scripts Holding Company
ESRX
+$68.2M
4
ISRG icon
Intuitive Surgical
ISRG
+$58.9M
5
EXC icon
Exelon
EXC
+$55.9M

Sector Composition

1 Consumer Staples 14.62%
2 Real Estate 13.83%
3 Utilities 12.81%
4 Technology 10.68%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VOD icon
126
Vodafone
VOD
$36B
$406K 0.01%
11,871
-50,606
-81% -$1.71M
QCOM icon
127
Qualcomm
QCOM
$180B
$372K 0.01%
+4,998
New +$366K
KGC icon
128
Kinross Gold
KGC
$27.4B
$348K 0.01%
+123,500
New +$346K
WYNN icon
129
Wynn Resorts
WYNN
$10.2B
$340K 0.01%
+2,288
New +$393K
TFCFA
130
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$261K 0.01%
+6,792
New +$240K
GILD icon
131
Gilead Sciences
GILD
$169B
$219K 0.01%
+2,321
New +$240K
ANDV
132
DELISTED
Andeavor
ANDV
$146K ﹤0.01%
+1,967
New +$139K
FOSL icon
133
Fossil Group
FOSL
$249M
$137K ﹤0.01%
+1,234
New +$129K
GIL icon
134
Gildan
GIL
$9.92B
$123K ﹤0.01%
4,332
+200
+5% +$5.7K
CCJ icon
135
Cameco
CCJ
$38B
$38K ﹤0.01%
2,300
-177,800
-99% -$3.05M
AMAT icon
136
Applied Materials
AMAT
$445B
– –
-10,934
Closed -$236K
BCE icon
137
BCE
BCE
$20.6B
– –
-1,887
Closed -$81K
EIX icon
138
Edison International
EIX
$30B
– –
-79,530
Closed -$4.45M
EQIX icon
139
Equinix
EQIX
$99.5B
– –
-7,546
Closed -$1.6M
EXPE icon
140
Expedia Group
EXPE
$32.5B
– –
-27,793
Closed -$2.44M
FAST icon
141
Fastenal
FAST
$53.6B
– –
-93,752
Closed -$1.05M
HOLX
142
DELISTED
Hologic
HOLX
– –
-1,387,708
Closed -$33.8M
MEOH icon
143
Methanex
MEOH
$4.11B
– –
-23,800
Closed -$1.59M
META icon
144
Meta Platforms (Facebook)
META
$1.69T
– –
-37,376
Closed -$2.95M
MPC icon
145
Marathon Petroleum
MPC
$89.3B
– –
-187,332
Closed -$7.93M
NDAQ icon
146
Nasdaq
NDAQ
$53.3B
– –
-370,914
Closed -$5.25M
OVV icon
147
Ovintiv
OVV
$15.9B
– –
-29,900
Closed -$3.18M
PVH icon
148
PVH
PVH
$3.68B
– –
-22,568
Closed -$2.73M
SWK icon
149
Stanley Black & Decker
SWK
$14.2B
– –
-349,913
Closed -$31.1M
VET icon
150
Vermilion Energy
VET
$1.48B
– –
-600
Closed -$37K
3 4 5
6
7

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q4 2014 Portfolio in Review

As of Q4 2014, TOBAM held 158 positions worth $3.02B, down 15% from $3.54B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

TOBAM withdrew a net $664M in Q4 2014, closing 23 positions and reducing 69 holdings. Its most notable exit was Endo International plc, an estimated $49.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 8.4% a quarter earlier, followed by Real Estate and Utilities.

Against the trend, TOBAM opened a new position in SALIX PHARMACEUTICALS LTD DEL worth $50.3M.

  • TOBAM's largest Q4 2014 buy was SALIX PHARMACEUTICALS LTD DEL: 437,377 shares worth $50.3M.
  • TOBAM added most to Clorox in Q4 2014, an estimated $75.6M increase.
  • TOBAM's biggest Q4 2014 reduction was Quest Diagnostics, cutting an estimated $109M.
  • TOBAM fully exited Endo International plc in Q4 2014, selling an estimated $49.1M.
  • TOBAM's ten largest holdings make up 32% of its $3.02B portfolio in Q4 2014.
  • TOBAM opened 26 new positions and closed 23 in Q4 2014.
  • TOBAM's portfolio value fell 15% quarter-over-quarter to $3.02B.

Based on TOBAM's 13F filing for Q4 2014, filed 20 Feb 2015.